Search

Your search keyword '"Plutonium adverse effects"' showing total 307 results

Search Constraints

Start Over You searched for: Descriptor "Plutonium adverse effects" Remove constraint Descriptor: "Plutonium adverse effects"
307 results on '"Plutonium adverse effects"'

Search Results

101. [Comparative investigation of structural and gene somatic mutations in workers of nuclear chemical plants. II. Frequency of lymphocytes mutant in T-cell receptor loci].

102. Chromosome intra- and inter-changes determined by G-banding in radiation workers with in vivo exposure to plutonium.

103. [Emergency care for acute wound entering of plutonium and americium into the body (real case)].

104. Bound PCNA in nuclei of primary rat tracheal epithelial cells after exposure to very low doses of plutonium-238 alpha particles.

105. Lung cancer in Mayak workers.

106. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case-control study.

107. [Radiation damages to the human lung].

108. [Hemopoietic response to americium and plutonium exposure in nuclear industry workers].

109. [Clinical and functional tests for pulmonary hypertension and cor pulmonale in chronic pulmonary berylliosis and plutonium-induced pulmonary sclerosis].

110. A review of contributions of human tissue studies to biokinetics, bioeffects and dosimetry of plutonium in man.

111. Mortality and cancer morbidity experience of female workers at the British Nuclear Fuels Sellafield plant, 1946-1998.

112. Risk estimates for deterministic health effects of inhaled weapons grade plutonium.

113. Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor.

114. Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome.

115. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.

116. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data.

117. Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise.

118. Micronuclei and nuclear anomalies in urinary exfoliated cells of subjects in radionuclide-contaminated regions.

120. Risks to the public from historical releases of radionuclides and chemicals at the Rocky Flats Environmental Technology Site.

121. 239+240Pu and 137Cs concentrations for zooplankton and nekton in the Northwest Pacific and Antarctic Oceans (1993-1996).

122. [Radiation hazard in the use of radioisotopic neutralizers of static electricity].

123. Estimates of radiological risk from a terrorist attack using plutonium.

125. Plutonium and other alpha emitters in mushrooms from Poland, Spain and Ukraine.

126. The potential for studies in other nuclear installations. On the possibility of creating medico-dosimetry registries of workers at the Siberian Chemical Industrial Complex (SCIC) and the Mountain Chemical Industrial Complex (MCIC) in Tomsk, Krasnoyarsk.

127. Studies on the Ozyorsk population: health effects.

128. Studies on the Ozyorsk population: dosimetry.

129. Studies on the Techa river offspring cohort: health effects.

130. Semipalatinsk test site: introduction.

131. Fallout from nuclear tests: dosimetry in the Altai region.

132. Fallout from nuclear tests: health effects in Kazakhstan.

133. Studies on the Mayak nuclear workers: dosimetry.

134. Studies on the Mayak nuclear workers: health effects.

135. Studies on the extended Techa river cohort: cancer risk estimation.

136. Fallout from nuclear tests: health effects in the Altai region.

137. Mayak Production Association: introduction.

138. Developing additional resources.

139. Studies on the Techa river populations: dosimetry.

140. Fallout from nuclear tests: dosimetry in Kazakhstan.

141. A model for a comprehensive assessment of exposure and lifetime cancer incidence risk from plutonium released from the Rocky Flats Plant, 1953-1989.

142. Assessing the uniformity of plutonium alpha radiation dose in human lung: the Mayak experience.

143. Effect of uncertainty in transfer rates for the ICPR publication 67 biokinetic model on dose estimation for 239Pu from results of individual monitoring. International Commission on Radiological Protection.

144. No evidence for chromosomal instability in radiation workers with in vivo exposure to plutonium.

145. Lymphocyte chromosomal aberrations and their complexity induced in vitro by plutonium-239 alpha-particles and detected by FISH.

146. Risks of fatal cancer from inhalation of 239,240plutonium by humans: a combined four-method approach with uncertainty evaluation.

148. An opportunity for the millennium: investigating Nagasaki plutonium.

149. Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239 and amercium-241.

150. Ionizing radiation, part 2: some internally deposited radionuclides. Views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 14-21 June 2000.

Catalog

Books, media, physical & digital resources